These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7729736)

  • 1. Mutant p53 in patients with invasive cervical cancer stages IB to IIB.
    Kainz C; Kohlberger P; Gitsch G; Sliutz G; Breitenecker G; Reinthaller A
    Gynecol Oncol; 1995 May; 57(2):212-4. PubMed ID: 7729736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
    Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
    Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
    Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
    Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume.
    Trattner M; Graf AH; Lax S; Forstner R; Dandachi N; Haas J; Pickel H; Reich O; Staudach A; Winter R
    Gynecol Oncol; 2001 Jul; 82(1):11-6. PubMed ID: 11426955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant p53 product in patients with stage III cervical cancer.
    Gitsch G; Kainz C; Joura E; Breitenecker G
    Anticancer Res; 1992; 12(6B):2241-2. PubMed ID: 1295470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular space invasion and inflammatory stromal reaction as prognostic factors in patients with surgically treated cervical cancer stage IB to IIB.
    Kainz C; Gitsch G; Tempfer C; Heinzl H; Koelbl H; Breitecker G; Reinthaller A
    Anticancer Res; 1994; 14(5B):2245-8. PubMed ID: 7840530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of cytokeratins and carcinoembryonic antigen expression in primary surgically treated cervical cancer.
    Kainz C; Zeisler H; Kohlberger P; Gitsch G; Heinzl H; Breitenecker G; Reinthaller A
    Anticancer Res; 1994; 14(2B):667-71. PubMed ID: 7516638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
    Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K
    Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 protein expression in squamous cell carcinoma of the vulva.
    Scheistrøen M; Tropé C; Pettersen EO; Nesland JM
    Cancer; 1999 Mar; 85(5):1133-8. PubMed ID: 10091798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of Bax, Bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy.
    Wootipoom V; Lekhyananda N; Phungrassami T; Boonyaphiphat P; Thongsuksai P
    Gynecol Oncol; 2004 Sep; 94(3):636-42. PubMed ID: 15350352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: overexpression of p53 predicts poor disease outcome.
    Huang LW; Chou YY; Chao SL; Chen TJ; Lee TT
    Gynecol Oncol; 2001 Nov; 83(2):348-54. PubMed ID: 11606096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix.
    Hedman H; Lindström AK; Tot T; Stendahl U; Henriksson R; Hellberg D
    Acta Oncol; 2010 Aug; 49(6):812-5. PubMed ID: 20553099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53, p21 and p27 protein expression in head and neck cancer and their prognostic value.
    Kapranos N; Stathopoulos GP; Manolopoulos L; Kokka E; Papadimitriou C; Bibas A; Yiotakis J; Adamopoulos G
    Anticancer Res; 2001; 21(1B):521-8. PubMed ID: 11299798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p53, Ki-67, and CD31 in the vaginal margins of radical hysterectomy in patients with stage IB carcinoma of the cervix.
    Silva-Filho AL; Traiman P; Triginelli SA; Reis FM; Pedrosa MS; Miranda D; Abreu ES; Macarenco RS; Cunha-Melo JR
    Gynecol Oncol; 2004 Dec; 95(3):646-54. PubMed ID: 15581977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 protein expression in resected invasive esophageal cancer.
    Chyczewski L; Kozłowski M; Nikliński J; Szyszko J; Laudański J; Niklińska W
    Neoplasma; 1999; 46(3):150-5. PubMed ID: 10613589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival.
    Hazelbag S; Kenter GG; Gorter A; Dreef EJ; Koopman LA; Violette SM; Weinreb PH; Fleuren GJ
    J Pathol; 2007 Jul; 212(3):316-24. PubMed ID: 17503414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in pathologic parametrium-positive patients with stage IB-IIB cervical cancer treated by radical surgery and adjuvant therapy.
    Kodama J; Seki N; Nakamura K; Hongo A; Hiramatsu Y
    Gynecol Oncol; 2007 Jun; 105(3):757-61. PubMed ID: 17433424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
    Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
    Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splice variants of CD44 in human cervical cancer stage IB to IIB.
    Kainz C; Kohlberger P; Sliutz G; Tempfer C; Heinzl H; Reinthaller A; Breitenecker G; Koelbl H
    Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.